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Received October 1, 2014; accepted January 6, 2015AbstractBackground: Trans-inferior petrous sinus (IPS) coil embolization is an efficient and safe method to manage cavernous sinus dural arteriovenous
fistulas (CSDAVFs). However, some CSDAVFs may be associated with angiographic occlusive IPS making access difficult. The purpose of this
study was to report our experience of transvenous embolization of the CSDAVF via angiographic occlusive IPS.
Methods: We reviewed the cases of 20 patients who underwent transvenous embolization via angiographic occlusive IPS over a 6 year period.
The study consisted of seven men and 13 women, ranging from 46 years to 78 years of age (mean, 60 years). We retrospectively analyzed the
angioarchitecture of the CSDAVFs, the procedural time and the angiographic as well as the clinical outcomes after embolization.
Results: True occlusive IPS was found in 13 of the patients, while patent IPS with compartment of the IPS-CS was demonstrated in the remaining
seven patients. The microcatheter was successfully navigated to the fistula site of the CS in 16 patients (80%), while such navigation failed in four
patients following numerous attempts. The mean procedural times for truly occlusive IPS and for compartment of the IPS-CS were 111 minutes
and 129 minutes, respectively. No recurrent fistula was observed on follow-up neuroimages. Three patients had transient third or sixth cranial nerve
palsy, and one patient had perforation of the IPS leading to temporary headache. The mean clinical follow-up period was 18 months.
Conclusion: Angiographic occlusive IPS of CSDAVF may be related to true occlusion of IPS or patent IPS with compartment of the IPS-CS.
There is no statistically significant difference in procedural times for these two different fistula anatomies. Transvenous embolization via
angiographic occlusive IPS is a safe and effective method to manage CSDAVFs.
Copyright © 2015 Elsevier Taiwan LLC and the Chinese Medical Association. All rights reserved.
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Cavernous sinus dural arteriovenous fistulas (CSDAVFs) are
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CSDAVFs are low-flow shunts presenting with benign neuro-
ophthalmic symptoms such as ocular-orbital venous conges-
tion, cephalic bruit and/or impairment of visual acuity.1e6
However, certain CSDAVFs with insufficient venous drains
may have pial venous reflux associated with the potential risk
of hemorrhagic or nonhemorrhagic neurologic deficit.2,3 Trans-
inferior petrous sinus (IPS) coil embolization is a safe and
effective method to manage CSDAVFs that require
treatment.4e6 Nevertheless, this access route may become
difficult in CSDAVFs due to angiographic occlusive IPSs.ociation. All rights reserved.
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tecture of CSDAVFs with angiographic occlusive IPS, and to
report our experience and outcomes using transvenous coil
embolization.
2. Methods
From May 2008 to April 2014, a total of 67 patients with 71
CSDAVFs were referred to our institute for endovascular
embolization because of progressive neuro-ophthalmic symp-
toms. From available records, we enrolled 57 patients with
CSDAVFs undergoing trans-IPS coil embolization via the IPS.
Of these 57 CSDAVF patients, 20 underwent transvenous
embolization via angiographic occlusive IPS. Before this
article was initiated, informed consent was obtained from all
20 patients. The clinical data of the 20 patients are summa-
rized in Table 1. These patients comprised seven men and 13Table 1
Demographics and clinical outcomes of 20 patients with cavernous sinus dural
inferior petrous sinus (IPS) embolization.
Patient/sex/age (y),
mean ¼ 60 y
Clinical manifestations Occlusive
or patent IPS
Fistulae fl
drainage
1/M/62 Chemosis, ophthalmalgia Occlusive SOV, SMC
2/F/67 Chemosis, impairment
of visual acuity
Occlusive SOV, C-C
C-SOV
3/M/55 Chemosis, bruit,
impairment of visual
acuty
Patent SOV, C-C
C-SOV
4/F/48 Chemosis, bruit Occlusive SOV, SMC
5/M/51 Chemosis, proptosis Patent SOV
6/F/58 Chemosis, bruit,
ophthalmalgia
Occlusive SOV, C-C
C-SOV
7/F/52 Chemosis, impairment
of visual acuity
Occlusive SOV, SMC
8/F/66 Chemosis, proptosis,
ophthalmalgia
Occlusive SOV, SMC
SPS
9/F/64 Chemosis, proptosis,
ophthalmalgia
Patent SOV, C-C
C-SOV
10/F/47 Chemosis, impairment
of visual acuity
Patent SOV, SPS
11/M/52 Chemosis, proptosis Occlusive SOV
12/F/72 Chemosis, proptosis,
ophthalmalgia
Patent SOV, SMC
13/F/59 Proptosis, impairment
of visual acuity
Occlusive C-CS,C-S
14/M/54 Chemosis, diplopia Occlusive SOV
15/M/46 Chemosis, proptosis Occlusive SOV, SMC
16/F/67 Chemosis, impairment
visual acuity
Occlusive SOV, SPS
17/F/72 Chemosis, ophthalmalgia Occlusive SOV, SPS
18/F/78 Limb weakness,
respiratory failure
Occlusive Pontomed
vein
19/M/53 Hemiparesis, aphasia Patent SOV, SMC
20/F/67 Chemosis Patent Cerebellar
SPS, SOV
C-CS¼ contralateral cavernous sinus; CN ¼ cranial nerve; C-SOV¼ contralateral s
sinus; NA ¼ not available; SMCV ¼ superficial middle cerebral vein; SOV ¼ supwomen with ages ranging from 46 years to 78 years (mean, 60
years). Transvenous embolization via occlusive IPS was per-
formed under general anesthesia using bilateral femoral ap-
proaches with 5 French (F) and 6F femoral sheath (Prelude,
Merit Medical system, Inc., South Jordan, Utah, USA)
placements to the left femoral artery and right femoral vein,
respectively. Activated clotting time was monitored and
maintained at a value of twice the baseline value by intrave-
nous administration of heparin. A 4 F diagnostic catheter was
positioned in the feeding carotid artery as a guide for subse-
quent transvenous embolization. A 6 F guiding catheter
(Envoy; Codman & Shurtleff, Rayhnam, MA, USA) was
placed into the internal jugular vein (IJV) for the retrograde
catheterization of angiographic occlusive IPS. CSDAVFs were
demonstrated by carotid roadmaps, and a 2 tip 0.017 inch
microcatheter (Headway; MicroVention Inc., Tustin, CA, USA
or Echelon; Covidien, Minneapolis, MN, USA) and a 0.014arteriovenous fistulas (CSDAVFs), managed by trans-angiographic occlusive
ow Procedural
time (min),
mean ¼ 123
min
Angiographic
outcome
Complication Clinical
follow-up
(mo),
mean ¼
18 mo
V 101 Cure Nil 11
S 107 Cure Nil 25
S 157 Cure Nil 21
V 103 Cure Nil 18
137 Cure Nil 17
S, 162 Cure Transient
CN3 palsy
8
V 138 Cure Nil 19
V, 98 Cure Nil 14
S, 115 Cure Nil 10
97 Cure Nil 15
153 Cure Nil 24
V 147 Cure Transient
CN3 palsy
24
OV 107 Cure IPS perforation 17
failure Cured by
transfacial
vein
Nil 7
V 116 Cure Nil 31
123 Cure Transient
CN6 palsy
21
failure Refer to GKS Nil NA
ullary failure Cured by
direct puncture
Nil 34
V 106 Cure Nil 13
vein, failure Refer to GKS Nil NA
uperior ophthalmic vein; GKS ¼ Gamma Knife surgery; IPS ¼ inferior petrous
erior ophthalmic vein; SPS ¼ superior petrous sinus.
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prepared. We attempted to use these devices to select and
advance to the IPS and fistula site. Once the microcatheter was
navigated into the CS, gentle and slow injection of a small
amount of contrast through the microcatheter was performed
to identify its position and the flow of contrast media. If there
was any risk of injury to, or perforation of the IPS/CS, hand
injection angiography was performed via the microcatheter to
delineate the angioarchitecture and hemodynamics of the
CSDAVFs. In addition, the procedural time of successful
embolization of CSDAVF was measured from the time
recorded on the diagnostic angiogram, and that time noted on
postembolization carotid angiograms.
Truly occlusive IPS was assumed when pre-embolization
carotid angiograms showed partial opacification of the prox-
imal IPS without a direct connection with the IJV (Fig. 1), or
when the hand injection angiogram demonstrated irregular,
stenotic/occlusive IPS. Patent IPS with compartment of the
IPS-CS was assumed if there was smooth navigation of the
catheter/guidewire into the IPS. However, if there was diffi-
culty in passage of the catheter or guidewire system to the
fistula site (Fig. 2), hand injection angiograms demonstrated
normal opacification of the IPS without communication of the
CSDAVF (Fig. 2). Once the microcatheter was in the ideal
fistula position and was confirmed by hand injection angiog-
raphy, transvenous coil occlusion of the fistulous zone was
performed. Occlusion of the CSDAVFs was commenced by
selecting the proper detachable coils (Microplex and Hydro-
coil; MicroVention Inc.) that would be used to pack the CS,
taking care not to create an occlusion of the outflow of fistula
drains with redirection of the fistulous flow toward the pial
veins. Control digital subtraction angiography (DSA) images
were obtained intermittently to evaluate the hemodynamics of
CSDAVFs. The endpoint of the endovascular procedure was
failure to access the fistula site of the CS after more than a 120
minute attempt, or successful access to the fistula site with
complete occlusion of the fistula flow by coiling, or slow flow
of the fistula after coiling associated with recoil of the
microcatheter back into the IPS.
A post embolization angiogram was carried out immedi-
ately after the completion of the procedure to check for oc-
clusion of the fistula. Of these 20 CSDAVF patients, 18 had
neuroimaging follow-up. Conventional DSA was obtained for
15 patients, while magnetic resonance angiography was used
for eight patients to evaluate the embolized CSDAVFs (mean,
8 months). Eighteen patients were followed up clinically for
an average of 18 months (range, 7e34 months).
3. Results
The clinical findings and treatment outcomes of 20
CSDAVF patients are summarized in Table 1. The clinical
manifestations of these patients were chemosis (n ¼ 17, 85%),
bruit (n ¼ 3, 15%), proptosis (n ¼ 7, 35%), ophthalmalgia
(n ¼ 6, 30%), impairment of visual acuity (n ¼ 6, 30%),
hemorrhagic (n ¼ 1, 5%) or nonhemorrhagic neurologic
deficit (n ¼ 1, 5%) or respiratory failure (n ¼ 1, 5%). Trueocclusive IPS was found in 13 (65%) CSDAVF patients, while
patent IPS with compartment of the IPS-CS was demonstrated
in seven (35%) CSDAVF patients. Most fistula flow drained to
the superior ophthalmic vein (SOV; n ¼ 18, 90%). However,
there was contralateral CS/SOV drainage in five (25%)
CSDAVF patients, and superior petrous sinus drainage in five
(25%) patients. While fistula reflux to pial veins occurred in
nine (45%) patients, only two (10%) patients presented with
aggressive neurologic behaviors (brain stem edema ¼ 1,
intracerebral hemorrhage ¼ 1).
Successful navigation of the microcatheter into the fistula
site of the CSDAVF was achieved in the case of 16 patients
(80%), whereas the procedure failed for four patients after
many attempts. Two of these patients had undergone Gamma
Knife radiosurgery 5 years and 6 years earlier, prior to
embolization with residual fistula; they were then referred
back to Gamma Knife radiosurgery to ascertain the feasibility
of additional radiosurgery. The other two patients underwent
transfacial venous or direct puncture of the CS with successful
occlusion of the fistula in the same session. For 16 CSDAVF
patients with successful catheterization, the procedural time
ranged from 97 minutes to 162 minutes (mean, 123 minutes).
The mean procedural times in truly occlusive IPSs with
compartment of the IPS-CS were 111 minutes and 129 mi-
nutes, respectively ( p < 0.90).
Complete fistula closures were documented on immediate
postembolization angiograms in 15 CSDAVFs (Figs. 1 and 2);
one patient with residual fistula underwent transvenous Onyx
(Covidien) embolization with total fistula occlusion. Three
patients experienced temporary impairment of sixth (n ¼ 1)
and/or the third (n ¼ 2) cranial nerve function due to the coil
mass effect in the CS; this resolved completely within 8
months. One patient suffered perforation of the IPS by the
catheter/guidewire with small leakage of contrast media to the
subarachnoid space which led to a temporal headache. No
other significant procedure-related neurological complication
was observed in the 20 patients. For those 16 patients who
underwent successful embolization, their cephalic-ocular
symptoms and signs related to fistulas such as bruit, chemo-
sis, proptosis, and cranial nerve palsy gradually resolved after
endovascular treatment. No evidence of recurrent or residual
CSDAVF was demonstrated in these 16 treated patients
through neuroimaging follow-up.
4. Discussion
CSDAVFs usually occur in middle-aged women and are fed
by multiple small dural branches of the carotid arteries.
Because of their slow-flow shunts, some CSDAVFs have a
tendency to undergo spontaneous thrombosis with clinical and
morphologic cures. Regarding management of CSDAVFs, if
patients present with mild clinical symptoms, with no angio-
graphic risk of hemorrhagic or nonhemorrhagic neurologic
deficits, conservative treatment or a less invasive procedure
such as observation, manual compression of the carotid artery7
or radiosurgery8 can be applied. If patients have pial reflux
and/or are at risk of clinical deterioration such as gradual loss
Fig. 1. A 66-year-old woman had right cavernous sinus dural arteriovenous fistula (CSDAVF) and presented with chemosis, proptosis, and ophthalmalgia. (A, B)
Right lateral internal and external carotid angiograms revealed CSDAVFs with truly occlusive distal inferior petrous sinus (IPS; indicated by arrow) with pial reflux
(indicated by arrowheads). (C, D) Transocclusive IPS embolization was performed with successful navigation of a microcatheter into the fistula site, as confirmed
by hand injection angiograms. (E) A postembolization carotid angiogram demonstrated total occlusion of the fistula.
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required.2,3,9,10 In our series, truly occlusive IPSs were
demonstrated in 13 patients. However, insufficient fistula
drains only occurred in two patients presenting with hemor-
rhagic (n ¼ 1) or nonhemorrhagic stroke (n ¼ 1). Other pa-
tients presented with ocular symptoms, largely because of the
fistula flow diversion to other venous pathways such ascontralateral CS, ophthalmic vein, and/or superior petrous
sinus.
There are two endovascular treatment modalities to manage
CSDAVFs: (1) transarterial embolization of arterial feeders
and (2) transvenous CS embolization. Some studies have
shown a good outcome with low complication rates for
occluding CSDAVFs via a transarterial route by using liquid
Fig. 2. (A) A 53-year-old man had left aggressive cavernous sinus dural arteriovenous fistula (CSDAVF) and presented with hemiparesis and dysphasia because of
ischemic stroke with hemorrhagic transformation at the left fronto-temporal lobes. (BeD). Pre-embolization carotid angiograms showed CSDAVF fed by dural
branches of bilateral carotid arteries (indicated by arrows), drained to the left ophthalmic vein and refluxed to the left superficial middle cerebral vein (indicated by
arrowheads). (EeG). Transvenous inferior petrous sinus (IPS) embolization was attempted, navigation of the catheter/guidewire into the IPS was smooth, but
further advancement of the catheter/guidewire was difficult because of compartment of the IPS-CS (indicated by white arrow). The catheter was eventually
successfully navigated into the CSDAVF; recoil of the catheter into the IPS after coiling of the CSDAVF was found, and hand injection angiogram confirmed patent
IPS with compartment of the IPS-CS. (HeJ) Postembolization carotid angiograms demonstrated total fistula occlusion.
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feasible, because of multiple, small, and tortuous feeders of
CSDAVFs. Furthermore, some risks may occur by inadvertent
embolization of carotid territory with ischemic stroke via
dangerous anastomosis of the externaleinternal carotid artery
or embolization of feeders of cranial nerves. By contrast,
transvenous coil embolization of the CSDAVF by occlusion of
the affected CS is considered safe, with promising results.4,6
Choosing an appropriate transvenous route depends on the
compartment of the CS involved in the fistula and its venous
drainage. By far, the most common venous route is via the IPS
by navigation of a guiding catheter to the IJV, then retrograde
microcatheterization of the IPS up to the fistula site in the CS.
This route is short, direct, and more easily accessed than other
routes. This access is particularly useful in CSDAVFs with
exclusive posterior drainage to patent IPS. However, this
technique may not always be feasible in difficult fistula
anatomies, particularly in patients with stenosis or occlusionof the IPS. Shiu et al12 reported that the IPS could not be
catheterized in 31% of cases due to its complex angioarchi-
tecture. Previous studies also demonstrated that the IPS had
numerous anastomoses with surrounding veins.13,14 Mitsuha-
shi et al14 reported that six types of venous drainage of the IPS
depended on the level insertion of the IPS into the IJV and
connection with surrounding veins. Therefore, a detailed
knowledge of the anatomy of the IPSeIJV junction and pre-
embolization work-up angioarchitecture analysis is essential
to increase the success rate of catheterization and reduce the
procedural time.
Angiographic nonopacification of the IPSs of CSDAVFs is
due to a variety of factors and may relate to true occlusion,
compartment of the IPS-CS, or agenesis. In cases of true oc-
clusion of the IPS, diagnostic carotid angiograms usually
demonstrated partial opacification of the proximal IPS because
of the fistula flow; there being no direct connection of IPS-IJV.
Hand injection angiograms via a microcatheter in the IPS
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IPS is patent with compartment of the IPS-CS, the fistula flow
usually uses an alternate drainage pathway, such as the supe-
rior ophthalamic vein and/or the superficial middle cerebral
vein. Pre-embolization carotid angiograms usually disclose the
dense opacification of the CS because of fistula flow; the
patent IPS can only be demonstrated in the hand injection IPS
angiogram or on rare occasions, in the later normal venous
phases of carotid angiograms.
Access to the CS through an angiographic nonopacified
IPS was first described by Hallbach et al15 in 1988. Subse-
quently, some small and sporadic series reported the success
rate varied from 50% to 75%.16,17 In our series, we had
successful navigation of the microcatheter into the fistula site
with the achievement of total fistula occlusion in 16 of 20
patients (80%). This result is slightly better than previously
reported, thanks to more highly developed access devices,
high-quality images, and experience in catheterization
through the venous route. In this series, we failed to access
the fistula via angiographic occlusive IPSs in four patients;
two were truly occlusive IPSs, the other two patients had
patent IPSs with compartment of the IPS-CS. The success of
catheterization to the fistula site in angiographic occlusive
IPS is theoretically related to the timing of thrombosis in the
IPS/CS and/or fistula anatomy (e.g., length of true occlusion).
Chronic occlusive IPS with solid thrombosis is a strong
barrier for passage of the catheter/guidewire system to the
fistula as evidenced by Patients 17 and 20, with 5- and 6-year
histories of CSDAVFs, respectively. By contrast, soft throm-
bosis is easier and more feasible to pass than those with
chronic occlusion. Length of occlusion is another factor
associated with the success of navigation, where short
segment occlusion such as that seen with Patient 5 (Fig. 1) is
easily passable compared to those with longer segment
occlusion.
In our experience, we found the major difficulty in navi-
gation of microcatheter to the CS via angiographic occlusive
IPS is to find the orifice of the IPS-IJV because of blind
navigation of the microcatheter due to a lack of roadmap
guiding. Therefore pre-embolization understanding of the
various insertion locations of the IPS-IJV is crucial. In those
CSDAVFs with patent IPS with compartment of the IPS-CS,
the microcatheter could be easily navigated into the IPS, but
the difficulty lay in passing the septum in IPS-CS. By
contrast, navigation and advancement of the catheter/guide-
wire into IPS was difficult in cases of true occlusive IPS.
Once the catheter/guidewire was successfully navigated into
the CS, gentle manipulation and advancement of the catheter/
guidewire up to the fistula site were attempted. This proce-
dure usually takes time; therefore, patience with repeated
advancementewithdrawal procedures of the catheter/guide-
wire system, to find the true lumen of the IPS-CS, is neces-
sary. In this series, the procedural time for transvenous
detachable embolization ranged from 97 minutes to 162 mi-
nutes (mean, 123 minutes). The procedural timing in truly
occlusive IPS versus compartment of the IPS-CS was 111
minutes versus 129 minutes ( p < 0.90). There was nostatistical significance between the procedural times in these
two different fistula anatomies. Our strategy of transvenous
catheterization, if we failed to access to the fistula site after
120 minute attempts, was to give up this access route. Instead,
alternative routes, such as transfacial veins or direct puncture
of the CS/superior ophthalmic vein, were selected or the
patient was referred to undergo Gamma Knife radiosurgery,
depending on the angioarchitecture and the patient's clinical
manifestations.
The approach to the CS via the nonopacified IPS is
considered safe, even in cases where the IPS is not visualized
and there is a lack of roadmap guiding. Benndorf et al16 re-
ported no complications in their series of 14 patients. The
most serious complication of the transocclusive IPS emboli-
zation of CSDAVFs approach was injury or perforation of the
IPS leading to catastrophic hemorrhage. This complication
occurred mostly due to blind advancement of a sharp guide-
wire tip, stiffened by the catheter, and the narrow vascular
structure which, aggravated by powerful contrast injection,
led to enlargement of the perforation. To avoid this compli-
cation, careful and gentle manipulation of microcatheter/
guidewire system is crucial. Lekkhong et al17 utilized a 0.035
inch guidewire to access the IPS. They utilized this wire to
create a track and a roadmap by pulling out the wire for
subsequent microcatheterization, because the tip of a 0.035-
inch guidewire is rounded and less traumatic, especially
when it is constantly rotated. In our series, we preferred to
select a 0.014/0.017 inch catheter/guidewire system, largely
because the guidewire tip was softer due to recent de-
velopments in the technology. In addition, the diameter of the
guidewire was smaller than those of 0.035 inch, thus inducing
less traumatic hemorrhage once it perforates the IPS. On
occasion, the increase of intrasinus pressure during hand in-
jection angiogram may lead to catastrophic hemorrhage.
Therefore, we didn't recommend performing hand injection
angiograms before the catheter was successfully navigated
into the fistula site with back flow of the blood from the
microcatheter. In this series, we had one case with micro-
catheter perforation of the IPS leading to a small amount of
contrast leakage into the subarachnoid space associated with
temporary headache.
In conclusion, most CSDAVFs with angiographic occlusive
IPSs presented with benign process. Angiographic occlusive
IPS of CSDAVF may relate to truly occlusive IPS or patent
IPS with compartment of the IPS-CS. There is no statistically
significant difference in procedural times in these two different
fistula anatomies.
Transvenous embolization via angiographic occlusive IPS
is a feasible and effective method to manage CSDAVF with a
high success rate and a low rate of periprocedural risk.Acknowledgments
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